(October 13, 2023, 3:47 PM EDT) -- WASHINGTON, D.C. — A group of 24 states, a coalition of faith-based organizations and the generic manufacturer of the abortion drug mifepristone were among 14 entities that filed amicus curiae briefs with the U.S. Supreme Court on Oct. 12, urging it to grant a writ of certiorari to determine whether a circuit court erred in upholding a district court’s stay of the U.S. Food and Drug Administration’s 2016 amendments to mifepristone’s approval and the agency’s 2021 decision not to enforce its regulations during the COVID-19 pandemic....